Development of novel pharmacotherapeutics for tobacco dependence: Progress and future directions

Nicotine and Tobacco Research

Volumn 14, Issue 11, 2012, Pages 1300-1318

  Harmey, Dympna ^a   Griffin, Patrick R ^a   Kenny, Paul J ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; CLONIDINE; CYCLOSERINE; CYTISINE; DIANICLINE; EVP 6124; GALANTAMINE; GSK 598809; LABETALOL; LIBERTAL; MECLOZINE; METHYLPHENIDATE; NICOTINE; NICOTINE VACCINE; NICOTINIC AGENT; NICOTINIC RECEPTOR; NORTRIPTYLINE; PIOGLITAZONE; PROGESTERONE; RIMONABANT; SURINABANT; TOBACCO SMOKE; TOLCAPONE; TOPIRAMATE; UNCLASSIFIED DRUG; VARENICLINE;

DRUG EFFICACY; DRUG MECHANISM; FOOD AND DRUG ADMINISTRATION; HUMAN; NEUROBIOLOGY; PRIORITY JOURNAL; REVIEW; SMOKING CESSATION; TOBACCO DEPENDENCE;

DRUG APPROVAL; DRUG DESIGN; HUMANS; RECEPTORS, NICOTINIC; TOBACCO USE CESSATION PRODUCTS; TOBACCO USE DISORDER; VACCINES;

EID: 84868154649     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/nts201     Document Type: Review

References (201)

1. Albuquerque, E. X., Pereira, E. F., Castro, N. G., Alkondon, M., Reinhardt, S., Schroder, H., & Maelicke, A. (1995). Nicotinic receptor function in the mammalian central nervous system. Annual Reviews of the New York Academy of Sciences, 757, 48-72.
2. Amos, C. I., Spitz, M. R., & Cinciripini, P. (2010). Chipping away at the genetics of smoking behavior. Nature Genetics, 42(5), 366-368. doi:10.1038/ng0510-366
3. Amos, C. I., Wu, X., Broderick, P., Gorlov, I. P., Gu, J., Eisen, T., ... Houlston, R. S. (2008). Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nature Genetics, 40(5), 616-622. doi:ng.109 [pii]10.1038/ng.109
4. Anderson, D. J., Malysz, J., Gronlien, J. H., El Kouhen, R., Hakerud, M., Wetterstrand, C.,... Gopalakrishnan, M. (2009). Stimulation of dopamine release by nicotinic acetylcholine receptor ligands in rat brain slices correlates with the profile of high, but not low, sensitivity alpha4beta2 subunit combination. Biochemical Pharmacology, 78(7), 844-851. doi:S0006-2952(09)00493-6 [pii]10.1016/j.bcp.2009.06.024
5. Andoh, T., Itoh, H., Higashi, T., Saito, Y., Ishiwa, D., Kamiya, Y., & Yamada, Y. (2004). PKC-independent inhibition of neuronal nicotinic acetylcholine receptors by diacylglycerol. Brain Research, 1013(1), 125-133. doi:10.1016/j.brainres.2004.04.012
6. Anney, R. J., Lotfi-Miri, M., Olsson, C. A., Reid, S. C., Hemphill, S. A., & Patton, G. C. (2007). Variation in the gene coding for the M5 muscarinic receptor (CHRM5) influences cigarette dose but is not associated with dependence to drugs of addiction: evidence from a prospective population based cohort study of young adults. BMC Genetics, 8, 46. doi:10.1186/1471-2156-8-46
7. Ashton, H., Stepney, R., & Thompson, J. W. (1979). Selftitration by cigarette smokers. British Medical Journal, 2(6186), 357-360.
8. Aubin, H. J., Bobak, A., Britton, J. R., Oncken, C., Billing, C. B., Jr., Gong, J.,... Reeves, K. R. (2008). Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trial. Thorax, 63(8), 717-724. doi:thx.2007.090647 [pii] 10.1136/thx.2007.090647
9. Azam, L., Winzer-Serhan, U. H., Chen, Y., & Leslie, F. M. (2002). Expression of neuronal nicotinic acetylcholine receptor subunit mRNAs within midbrain dopamine neurons. Journal of Comparative Neurology, 444(3), 260-274.
10. Baker, D. A., McFarland, K., Lake, R. W., Shen, H., Tang, X. C., Toda, S., & Kalivas, P. (2003). Neuroadaptations in cystine-glutamate exchange underlie cocaine relapse. Nature Neuroscience, 6(7), 743-749. doi:10.1038/nn1069
11. Barlow, R. B., & McLeod, L. J. (1969). Some studies on cytisine and its methylated derivatives. British Journal of Pharmacology, 35(1), 161-174.
12. Bartlett, S., & Heilig, M. (2011). Translational approaches to medication development. Current Topics in Behavioral Neurosciences. doi:10.1007/7854_2011_132
13. Benndorf, S., Scharfenberg, G., Kempe, G., Wendekamm, R., & Winkelvoss, E. (1970). Smoking withdrawal treatment with Cytisin (Tabex). Results of a semi-annual survey of former smokers after 4 weeks of therapy. Dtsch Gesundheitsw, 24(17), 774-776.
14. Benowitz, N. L. (2009). Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics. Annual Review of Pharmacology and Toxicology, 49, 57-71. doi:10.1146/annurev. pharmtox.48.113006.094742
15. Berrettini, W., Yuan, X., Tozzi, F., Song, K., Francks, C., Chilcoat, H.,... Mooser, V. (2008). Alpha-5/alpha-3 nicotinic receptor subunit alleles increase risk for heavy smoking. Molecular Psychiatry, 13(4), 368-373.
16. Bespalov, A. Y., Dravolina, O. A., Sukhanov, I., Zakharova, E., Blokhina, E., Zvartau, E.,... Markou, A. (2005). Metabotropic glutamate receptor (mGluR5) antagonist MPEP attenuated cueand schedule-induced reinstatement of nicotine self-administration behavior in rats. Neuropharmacology, 49(Suppl. 1), 167-178. doi:S0028-3908(05)00221-2 [pii]10.1016/j. neuropharm.2005.06.007
17. Besson, M., David, V., Baudonnat, M., Cazala, P., Guilloux, J. P., Reperant, C.,... Granon, S. (2012). Alpha7-nicotinic receptors modulate nicotine-induced reinforcement and extracellular dopamine outflow in the mesolimbic system in mice. Psychopharmacology (Berl), 220(1), 1-14. doi:10.1007/s00213-011-2422-1
18. Bierut, L. J., Stitzel, J. A., Wang, J. C., Hinrichs, A. L., Grucza, R. A., Xuei, X.,... Goate, A. M. (2008). Variants in nicotinic receptors and risk for nicotine dependence. American Journal of Psychiatry, 165(9), 1163-1171. doi:10.1176/appi. ajp.2008.07111711
19. Borrelli, E., Nestler, E. J., Allis, C. D., & Sassone-Corsi, P. (2008). Decoding the epigenetic language of neuronal plasticity. Neuron, 60(6), 961-974. doi:10.1016/j.neuron.2008.10.012
20. Boules, M., Oliveros, A., Liang, Y., Williams, K., Shaw, A., Robinson, J.,... Richelson, E. (2011). A neurotensin analog, NT69L, attenuates intravenous nicotine self-administration in rats. Neuropeptides, 45(1), 9-16. doi:10.1016/j.npep.2010.09.003
21. Brindley, D. N., & Waggoner, D. W. (1998). Mammalian lipid phosphate phosphohydrolases. The Journal of Biological Chemistry, 273(38), 24281-24284.
22. Bromberg-Martin, E. S., & Hikosaka, O. (2011). Lateral habenula neurons signal errors in the prediction of reward information. Nature Neuroscience, 14(9), 1209-1216. doi:10.1038/nn.2902
23. Bruijnzeel, A. W., Ford, J., Rogers, J. A., Scheick, S., Ji, Y., Bishnoi, M., & Alexander, J. (2012). Blockade of CRF1 receptors in the central nucleus of the amygdala attenuates the dysphoria associated with nicotine withdrawal in rats. Pharmacology, Biochemistry and Behavior, 101(1), 62-68. doi:10.1016/j. pbb.2011.12.001
24. Brunzell, D. H., Boschen, K. E., Hendrick, E. S., Beardsley, P. M., & McIntosh, J. M. (2010). Alpha-Conotoxin MII-sensitive nicotinic acetylcholine receptors in the nucleus accumbens shell regulate progressive ratio responding maintained by nicotine. Neuropsychopharmacology, 35(3), 665-673. doi:npp2009171 [pii]10.1038/npp.2009.171
25. Brunzell, D. H., & McIntosh, J. M. (2012). Alpha7 nicotinic acetylcholine receptors modulate motivation to self-administer nicotine: implications for smoking and schizophrenia. Neuropsychopharmacology, 37(5), 1134-1143. doi:10.1038/npp.2011.299
26. Buisson, B., & Bertrand, D. (2002). Nicotine addiction: the possible role of functional upregulation. Trends in Pharmacological Sciences, 23(3), 130-136.
27. Butt, C. M., Hutton, S. R., Marks, M. J., & Collins, A. C. (2002). Bovine serum albumin enhances nicotinic acetylcholine receptor function in mouse thalamic synaptosomes. Journal of Neurochemistry, 83(1), 48-56.
28. Cahill, K., & Ussher, M. (2007). Cannabinoid type 1 receptor antagonists (rimonabant) for smoking cessation. Cochrane Database of Systematic Reviews, 4, CD005353. doi:10.1002/14651858.CD005353.pub3
29. Carrera, M. R., Ashley, J. A., Hoffman, T. Z., Isomura, S., Wirsching, P., Koob, G. F., & Janda, K. D. (2004). Investigations using immunization to attenuate the psychoactive effects of nicotine. Bioorganic & Medicinal Chemistry, 12(3), 563-570.
30. Cashman, J. R., Okolotowicz, K., Cerny, M., Johnson, R., Janowsky, A., & Azar, M. R. (2012). Substituted heteroaromatic compounds: effect on nicotine self-administration in rats. Psychopharmacology (Berl). doi:10.1007/s00213-011-2608-6
31. Catz, S. L., Jack, L. M., McClure, J. B., Javitz, H. S., Deprey, M., Zbikowski, S. M.,... Swan, G. E. (2011). Adherence to varenicline in the COMPASS smoking cessation intervention trial. Nicotine &Tobacco Research, 13(5), 361-368. doi:10.1093/ntr/ntr003
32. Champtiaux, N., Gotti, C., Cordero-Erausquin, M., David, D. J., Przybylski, C., Lena, C.,... Changeux, J. P. (2003). Subunit composition of functional nicotinic receptors in dopaminergic neurons investigated with knock-out mice. Journal of Neuroscience, 23(21), 7820-7829. doi:23/21/7820 [pii]
33. Champtiaux, N., Han, Z. Y., Bessis, A., Rossi, F. M., Zoli, M., Marubio, L.,... Gangeux, J. P. (2002). Distribution and pharmacology of alpha 6-containing nicotinic acetylcholine receptors analyzed with mutant mice. Journal of Neuroscience, 22(4), 1208-1217.
34. Chen, X., Che, Y., Zhang, L., Putman, A. H., Damaj, I., Martin, B. R.,... Miles, M. F. (2007). RhoA, encoding a Rho GTPase, is associated with smoking initiation. Genes, Brain, and Behavior, 6(8), 689-697. doi:10.1111/j.1601-183X.2006.00296.x
35. Chiamulera, C., Epping-Jordan, M. P., Zocchi, A., Marcon, C., Cottiny, C., Tacconi, S.,... Conquet, F. (2001). Reinforcing and locomotor stimulant effects of cocaine are absent in mGluR5 null mutant mice. Nature Neuroscience, 4(9), 873-874. doi:10.1038/nn0901-873nn0901-873 [pii]
36. Chikama, M., McFarland, N. R., Amaral, D. G., & Haber, S. N. (1997). Insular cortical projections to functional regions of the striatum correlate with cortical cytoarchitectonic organization in the primate. Journal of Neuroscience, 17, 9686-9705.
37. Ciccocioppo, R. (2010). Compositions and methods for prophylaxis and treatment of addictions. International Patent PCT/US2010/02724.
38. Coe, J. W., Brooks, P. R., Vetelino, M. G., Wirtz, M. C., Arnold, E. P., Huang, J.,... O'Neill, B. T. (2005). Varenicline: an alpha-4beta2 nicotinic receptor partial agonist for smoking cessation. Journal of Medicinal Chemistry, 48(10), 3474-3477. doi:10.1021/jm050069n
39. Contreras, M., Ceric, F., & Torrealba, F. (2007). Inactivation of the interoceptive insula disrupts drug craving and malaise induced by lithium. Science, 318(5850), 655-658. doi:10.1126/science.1145590
40. Corelli, R. L., & Hudmon, K. S. (2002). Medications for smoking cessation. Western Journal of Medicine, 176(2), 131-135.
41. Cuello, A. C., Emson, P. C., Paxinos, G., & Jessell, T. (1978). Substance P containing and cholinergic projections from the habenula. Brain Research, 149(2), 413-429.
42. Damaj, M. I., Grabus, S. D., Navarro, H. A., Vann, R. E., Warner, J. A., King, L. S.,... Carroll, F. I. (2010). Effects of hydroxymetabolites of bupropion on nicotine dependence behavior in mice. The Journal of Pharmacology and Experimental Therapeutics, 334(3), 1087-1095. doi:10.1124/jpet.110.166850
43. De Biasi, M., & Salas, R. (2008). Influence of neuronal nicotinic receptors over nicotine addiction and withdrawal. Experimental Biology and Medicine, 233(8), 917-929. doi:10.3181/0712-MR-355
44. Diehl, A., Nakovics, H., Croissant, B., Smolka, M. N., Batra, A., & Mann, K. (2006). Galantamine reduces smoking in alcoholdependent patients: a randomized, placebo-controlled trial. International Journal of Clinical Pharmacology and Therapeutics, 44(12), 614-622.
45. Doll, R., Peto, R., Boreham, J., & Sutherland, I. (2004). Mortality in relation to smoking: 50 years' observations on male British doctors. British Medical Journal, 328(7455), 1519. doi:10.1136/bmj.38142.554479.AEbmj.38142.554479.AE [pii]
46. Doll, R., Peto, R., Wheatley, K., Gray, R., & Sutherland, I. (1994). Mortality in relation to smoking: 40 years' observations on male British doctors. British Medical Journal, 309(6959), 901-911.
47. Dwoskin, L. P., Smith, A. M., Wooters, T. E., Zhang, Z., Crooks, P. A., & Bardo, M. T. (2009). Nicotinic receptor-based therapeutics and candidates for smoking cessation. Biochemical Pharmacology, 78(7), 732-743. doi:S0006-2952(09)00448-1 [pii]10.1016/j.bcp.2009.06.002
48. Eckenrode, T. C., Barr, G. A., Battisti, W. P., & Murray, M. (1987). Acetylcholine in the interpeduncular nucleus of the rat: normal distribution and effects of deafferentation. Brain Research, 418(2), 273-286.
49. Elgoyhen, A. B., Johnson, D. S., Boulter, J., Vetter, D. E., & Heinemann, S. (1994). Alpha 9: an acetylcholine receptor with novel pharmacological properties expressed in rat cochlear hair cells. Cell, 79(4), 705-715.
50. Elgoyhen, A. B., Vetter, D. E., Katz, E., Rothlin, C. V., Heinemann, S. F., & Boulter, J. (2001). Alpha10: a determinant of nicotinic cholinergic receptor function in mammalian vestibular and cochlear mechanosensory hair cells. Proceedings of the National Academy of Sciences U S A, 98(6), 3501-3506.
51. Ercan, Z. S., & Turker, R. K. (1985). Nicotine is a competitive antagonist for H1-receptors in smooth muscles. Archives Internationales de Pharmacodynamie et de Therapie, 274(1), 24-30.
52. Etter, J. F. (2006). Cytisine for smoking cessation: a literature review and a meta-analysis. Archives of Internal Medicine, 166(15), 1553-1559. doi:166/15/1553 [pii]10.1001/archinte.166.15.1553
53. Exley, R., Maubourguet, N., David, V., Eddine, R., Evrard, A., Pons, S.,... Faure, P. (2011). Distinct contributions of nicotinic acetylcholine receptor subunit alpha4 and subunit alpha6 to the reinforcing effects of nicotine. Proceedings of the National Academy of Sciences U S A, 108(18), 7577-7582. doi:10.1073/pnas.1103000108
54. Ezzati, M., & Lopez, A. D. (2003). Estimates of global mortality attributable to smoking in 2000. Lancet, 362(9387), 847-852. doi:S0140-6736(03)14338-3 [pii]10.1016/S0140-6736(03) 14338-3
55. Fagerstrom, K., & Balfour, D. J. (2006). Neuropharmacology and potential efficacy of new treatments for tobacco dependence. Expert opinion on Investigational Drugs, 15(2), 107-116. doi:10.1517/13543784.15.2.107
56. Feng, Z., Li, W., Ward, A., Piggott, B. J., Larkspur, E. R., Sternberg, P. W., & Xu, X. Z. (2006). A C. elegans model of nicotine-dependent behavior: regulation by TRP-family channels. Cell, 127(3), 621-633. doi:10.1016/j.cell.2006.09.035
57. Fernandez, J. R., & Allison, D. B. (2004). Rimonabant Sanofi-Synthelabo. Current Opinion in Investigational Drugs, 5(4), 430-435.
58. Fiore, M. C., Jaén, C. R., Baker, T. B., Bailey, W. C., Benowitz, N. L., Curry, S. J.,... Wewers, M. E. (2008). Treating tobacco use and dependence: 2008 update. Rockville, MD: Public Health Service.
59. Fletcher, P. J., Rizos, Z., Noble, K., Soko, A. D., Silenieks, L. B., Le, A. D., & Higgins, G. A. (2012). Effects of the 5-HT(2C) receptor agonist Ro60-0175 and the 5-HT(2A) receptor antagonist M100907 on nicotine self-administration and reinstatement. Neuropharmacology, 62(7), 2287-2297. doi:10.1016/j. neuropharm.2012.01.023
60. Flores, C. M., Rogers, S. W., Pabreza, L. A., Wolfe, B. B., & Kellar, K. J. (1992). A subtype of nicotinic cholinergic receptor in rat brain is composed of alpha 4 and beta 2 subunits and is up-regulated by chronic nicotine treatment. Molecular Pharmacology, 41(1), 31-37.
61. Forget, B., Pushparaj, A., & Le Foll, B. (2010). Granular insular cortex inactivation as a novel therapeutic strategy for nicotine addiction. Biological Psychiatry, 68(3), 265-271. doi:10.1016/j. biopsych.2010.01.029
62. Fowler, C. D., Lu, Q., Johnson, P. M., Marks, M. J., & Kenny, P. J. (2011). Habenular alpha5 nicotinic receptor subunit signalling controls nicotine intake. Nature, 471, 597-601. doi:10.1038/nature09797
63. Frahm, S., Slimak, M. A., Ferrarese, L., Santos-Torres, J., Antolin-Fontes, B., Auer, S.,... Ibanez-Tallon, I. (2011). Aversion to nicotine is regulated by the balanced activity of beta4 and alpha5 nicotinic receptor subunits in the medial habenula. Neuron, 70(3), 522-535. doi:10.1016/j.neuron.2011.04.013
64. Gamaleddin, I., Guranda, M., Goldberg, S. R., & Le Foll, B. (2011). The selective anandamide transport inhibitor VDM11 attenuates reinstatement of nicotine seeking behaviour, but does not affect nicotine intake. British Journal of Pharmacology, 164(6), 1652-1660. doi:10.1111/j.1476-5381.2011.01440.x
65. Genome-wide meta-analyses identify multiple loci associated with smoking behavior. (2010). Nature Genetics, 42(5), 441-447. doi:10.1038/ng.571
66. George, O., Ghozland, S., Azar, M. R., Cottone, P., Zorrilla, E. P., Parsons, L. H.,... Koob, G. F. (2007). CRF-CRF1 system activation mediates withdrawal-induced increases in nicotine self-administration in nicotine-dependent rats. Proceedings of the National Academy of Sciences U S A, 104(43), 17198-17203. doi:10.1073/pnas.0707585104
67. George, O., Lloyd, A., Carroll, F. I., Damaj, M. I., & Koob, G. F. (2011). Varenicline blocks nicotine intake in rats with extended access to nicotine self-administration. Psychopharmacology (Berl), 213(4), 715-722. doi:10.1007/s00213-010-2024-3
68. Girod, R., Barazangi, N., McGehee, D., & Role, L. W. (2000). Facilitation of glutamatergic neurotransmission by presynaptic nicotinic acetylcholine receptors. Neuropharmacology, 39(13), 2715-2725.
69. Goeders, N. E., Cohen, A., Fox, B. S., Azar, M. R., George, O., & Koob, G. F. (2012). Effects of the combination of metyrapone and oxazepam on intravenous nicotine self-administration in rats. Psychopharmacology (Berl). doi:10.1007/s00213-012-2682-4
70. Gotti, C., Guiducci, S., Tedesco, V., Corbioli, S., Zanetti, L., Moretti, M.,... Zoli, M. (2010). Nicotinic acetylcholine receptors in the mesolimbic pathway: primary role of ventral tegmental area alpha6beta2&z.ast; receptors in mediating systemic nicotine effects on dopamine release, locomotion, and reinforcement. Journal of Neuroscience, 30(15), 5311-5325. doi:10.1523/JNEUROSCI.5095-09.2010
71. Grady, S. R., Salminen, O., Laverty, D. C., Whiteaker, P., McIntosh, J. M., Collins, A. C., & Marks, M. J. (2007). The subtypes of nicotinic acetylcholine receptors on dopaminergic terminals of mouse striatum. Biochemical Pharmacology, 74(8), 1235-1246.
72. Gritz, E. R., Baer-Weiss, V., & Jarvik, M. E. (1976). Titration of nicotine intake with full-length and half-length cigarettes. Clinical pharmacology and Therapeutics, 20(5), 552-556.
73. Grottick, A. J., Trube, G., Corrigall, W. A., Huwyler, J., Malherbe, P., Wyler, R., & Higgins, G. A. (2000). Evidence that nicotinic alpha(7) receptors are not involved in the hyperlocomotor and rewarding effects of nicotine. Journal of Pharmacology & Experimental Therapeutics, 294(3), 1112-1119.
74. Grucza, R. A., Wang, J. C., Stitzel, J. A., Hinrichs, A. L., Saccone, S. F., Saccone, N. L.,... Bierut, L. J. (2008). A risk allele for nicotine dependence in CHRNA5 is a protective allele for cocaine dependence. Biological Psychiatry, 64(11), 922-929. doi:10.1016/j.biopsych.2008.04.018
75. Hays, J. T., & Ebbert, J. O. (2010). Adverse effects and tolerability of medications for the treatment of tobacco use and dependence. Drugs, 70(18), 2357-2372. doi:10.2165/11538190-000000000-00000
76. Higgins, G. A., Silenieks, L. B., Rossmann, A., Rizos, Z., Noble, K., Soko, A. D., & Fletcher, P. J. (2012). The 5-HT2C receptor agonist lorcaserin reduces nicotine self-administration, discrimination, and reinstatement: relationship to feeding behavior and impulse control. Neuropsychopharmacology, 37(5), 1177-1191. doi:10.1038/npp.2011.303
77. Hikosaka, O. (2010). The habenula: from stress evasion to valuebased decision-making. Nature reviews. Neuroscience, 11(7), 503-513. doi:10.1038/nrn2866
78. Hoft, N. R., Corley, R. P., McQueen, M. B., Schlaepfer, I. R., Huizinga, D., & Ehringer, M. A. (2009). Genetic association of the CHRNA6 and CHRNB3 genes with tobacco dependence in a nationally representative sample. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology, 34(3), 698-706. doi:10.1038/npp.2008.122
79. Hollander, J. A., Im, H. I., Amelio, A. L., Kocerha, J., Bali, P., Lu, Q.,... Kenny, P. J. (2010). Striatal microRNA controls cocaine intake through CREB signalling. Nature, 466(7303), 197-202. doi:10.1038/nature09202
80. Hollander, J. A., Lu, Q., Cameron, M. D., Kamenecka, T. M., & Kenny, P. J. (2008). Insular hypocretin transmission regulates nicotine reward. Proceedings of the National Academy of Sciences U S A, 105(49), 19480-19485. doi:10.1073/pnas.0808023105
81. Hung, R. J., McKay, J. D., Gaborieau, V., Boffetta, P., Hashibe, M., Zaridze, D.,... Brennan, P. (2008). A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature, 452(7187), 633-637. doi:10.1038/nature06885
82. Im, H. I., Hollander, J. A., Bali, P., & Kenny, P. J. (2010). MeCP2 controls BDNF expression and cocaine intake through homeostatic interactions with microRNA-212. Nature Neuroscience, 13(9), 1120-1127. doi:10.1038/nn.2615
83. Iordanidou, M., Tavridou, A., Petridis, I., Kyroglou, S., Kaklamanis, L., Christakidis, D., & Manolopoulos, V. G. (2010). Association of polymorphisms of the serotonergic system with smoking initiation in Caucasians. Drug and Alcohol Dependence, 108(1-2), 70-76. doi:10.1016/j.drugalcdep.2009.11.015
84. Ismayilova, N., & Shoaib, M. (2010). Alteration of intravenous nicotine self-administration by opioid receptor agonist and antagonists in rats. Psychopharmacology, 210(2), 211-220. doi:10.1007/s00213-010-1845-4
85. Jhou, T. C., Fields, H. L., Baxter, M. G., Saper, C. B., & Holland, P. C. (2009). The rostromedial tegmental nucleus (RMTg), a GABAergic afferent to midbrain dopamine neurons, encodes aversive stimuli and inhibits motor responses. Neuron, 61(5), 786-800. doi:10.1016/j.neuron.2009.02.001
86. Kagan, B. L., Sultzer, D. L., Rosenlicht, N., & Gerner, R. H. (1990). Oral S-adenosylmethionine in depression: a randomized, double-blind, placebo-controlled trial. American Journal of Psychiatry, 147(5), 591-595.
87. Kenny, P. J. (2011a). Tobacco dependence, the insular cortex and the hypocretin connection. Pharmacology, Biochemistry & Behavior, 97(4), 700-707. doi:10.1016/j.pbb.2010.08.015
88. Kenny, P. J., Chartoff, E., Roberto, M., Carlezon, W. A., Jr., & Markou, A. (2009). NMDA receptors regulate nicotineenhanced brain reward function and intravenous nicotine selfadministration: role of the ventral tegmental area and central nucleus of the amygdala. Neuropsychopharmacology, 34(2), 266-281. doi:npp200858 [pii]10.1038/npp.2008.58
89. Kenny, P. J., & Markou, A. (2001). Neurobiology of the nicotine withdrawal syndrome. Pharmacology, Biochemistry & Behavior, 70(4), 531-549.
90. Kenny, P. J., Paterson, N. E., Boutrel, B., Semenova, S., Harrison, A. A., Gasparini, F.,... Markou, A. (2003). Metabotropic glutamate 5 receptor antagonist MPEP decreased nicotine and cocaine self-administration but not nicotine and cocaineinduced facilitation of brain reward function in rats. Annual Reviews of the New York Academy of Sciences, 1003, 415-418.
91. Knackstedt, L. A., LaRowe, S., Mardikian, P., Malcolm, R., Upadhyaya, H., Hedden, S.,... Kalivas, P. W. (2009). The role of cystine-glutamate exchange in nicotine dependence in rats and humans. Biological Psychiatry, 65(10), 841-845. doi:S0006-3223(08)01388-7 [pii]10.1016/j.biopsych.2008.10.040
92. Knight, C., Howard, P., Baker, C. L., & Marton, J. P. (2009). The cost-effectiveness of an extended course (12 + 12 weeks) of varenicline compared with other available smoking cessation strategies in the United States: an extension and update to the BENESCO model. Value Health. doi:VHE672 [pii]10.1111/j.1524-4733.2009.00672.x
93. Kumar, A., Choi, K. H., Renthal, W., Tsankova, N. M., Theobald, D. E., Truong, H. T.,... Nestler, E. J. (2005). Chromatin remodeling is a key mechanism underlying cocaine-induced plasticity in striatum. Neuron, 48(2), 303-314. doi:10.1016/j. neuron.2005.09.023
94. Kuryatov, A., Onksen, J., & Lindstrom, J. (2008). Roles of accessory subunits in alpha4beta2(&z.ast;) nicotinic receptors. Molecular Pharmacology, 74(1), 132-143. doi:mol.108.046789 [pii]10.1124/mol.108.046789
95. Lapa, G. B., Mathews, T. A., Harp, J., Budygin, E. A., & Jones, S. R. (2005). Diphenylpyraline, a histamine H1 receptor antagonist, has psychostimulant properties. European Journal of Pharmacolology, 506(3), 237-240. doi:10.1016/j. ejphar.2004.11.017
96. LaPlant, Q., Vialou, V., Covington, H. E., 3rd, Dumitriu, D., Feng, J., Warren, B. L.,... Nestler, E. J. (2010). Dnmt3a regulates emotional behavior and spine plasticity in the nucleus accumbens. Nature Neuroscience, 13(9), 1137-1143. doi:10.1038/nn.2619
97. Le Marchand, L., Derby, K. S., Murphy, S. E., Hecht, S. S., Hatsukami, D., Carmella, S. G.,... Wang, H. (2008). Smokers with the CHRNA lung cancer-associated variants are exposed to higher levels of nicotine equivalents and a carcinogenic tobaccospecific nitrosamine. Cancer Research, 68(22), 9137-9140. doi:68/22/9137 [pii]10.1158/0008-5472.CAN-08-2271
98. Le Novere, N., Corringer, P. J., & Changeux, J. P. (2002). The diversity of subunit composition in nAChRs: evolutionary origins, physiologic and pharmacologic consequences. Journal of Neurobiology, 53(4), 447-456.
99. Le Novere, N., Zoli, M., & Changeux, J. P. (1996). Neuronal nicotinic receptor alpha 6 subunit mRNA is selectively concentrated in catecholaminergic nuclei of the rat brain. European Journal of Neuroscience, 8(11), 2428-2439.
100. Lecourtier, L., & Kelly, P. H. (2007). A conductor hidden in the orchestra? Role of the habenular complex in monoamine transmission and cognition. Neuroscience & Biobehavioral Reviews, 31(5), 658-672. doi:10.1016/j.neubiorev.2007.01.004
101. Lee, A. M., & Messing, R. O. (2011). Protein kinase C epsilon modulates nicotine consumption and dopamine reward signals in the nucleus accumbens. Peedings of the National Academy of Sciences U S A, 108(38), 16080-16085. doi:10.1073/pnas.1106277108
102. Lena, C., & Changeux, J. P. (1998). Allosteric nicotinic receptors, human pathologies. Journal of Physiology-Paris, 92(2), 63-74.
103. Lerman, C., LeSage, M. G., Perkins, K. A., O'Malley, S. S., Siegel, S. J., Benowitz, N. L., & Corrigall, W. A. (2007). Translational research in medication development for nicotine dependence. Nature Reviews Drug Discovery, 6(9), 746-762. doi:nrd2361 [pii]10.1038/nrd2361
104. Lesage, M. G., Perry, J. L., Kotz, C. M., Shelley, D., & Corrigall, W. A. (2010). Nicotine self-administration in the rat: effects of hypocretin antagonists and changes in hypocretin mRNA. Psychopharmacology (Berl), 209(2), 203-212. doi:10.1007/s00213-010-1792-0
105. Levin, E. D., Petro, A., Rezvani, A. H., Pollard, N., Christopher, N. C., Strauss, M.,... Rose, J. E. (2009). Nicotinic alpha7- or beta2-containing receptor knockout: effects on radial-arm maze learning and long-term nicotine consumption in mice. Behavioural Brain Research, 196(2), 207-213. doi:S0166-4328(08)00502-0 [pii]10.1016/j.bbr.2008.08.048
106. Levin, E. D., Rezvani, A. H., Xiao, Y., Slade, S., Cauley, M., Wells, C.,... Kellar, K. J. (2010). Sazetidine-A, a selective alpha4beta2 nicotinic receptor desensitizing agent and partial agonist, reduces nicotine self-administration in rats. Journal of Pharmacology & Experimental Therapeutics, 332(3), 933-939. doi:jpet.109.162073 [pii]10.1124/jpet.109.162073
107. Levin, E. D., Slade, S., Wells, C., Pruitt, M., Cousins, V., Cauley, M.,... Rose, J. (2011). Histamine H(1) antagonist treatment with pyrilamine reduces nicotine self-administration in rats. European Journal of Pharmacology, 650(1), 256-260. doi:10.1016/j.ejphar.2010.10.013
108. Levin, M. E., Weaver, M. T., Palmatier, M. I., Caggiula, A. R., Sved, A. F., & Donny, E. C. (2012). Varenicline dose dependently enhances responding for nonpharmacological reinforcers and attenuates the reinforcement-enhancing effects of nicotine. Nicotine& Tobacco Research, 14(3), 299-305. doi:10.1093/ntr/ntr213
109. Li, M. D.,Lou, X. Y., Chen, G., Ma, J. Z., & Elston, R. C. (2008). Gene-gene interactions among CHRNA4, CHRNB2, BDNF, and NTRK2 in nicotine dependence. Biological Psychiatry, 64(11), 951-957. doi:10.1016/j.biopsych.2008.04.026
110. Li, M. D., Mangold, J. E., Seneviratne, C., Chen, G. B., Ma, J. Z., Lou, X. Y., & Payne, T. J. (2009). Association and interaction analyses of GABBR1 and GABBR2 with nicotine dependence in European- and African-American populations. PloS one, 4(9), e7055. doi:10.1371/journal.pone.0007055
111. Liechti, M. E., Lhuillier, L., Kaupmann, K., & Markou, A. (2007). Metabotropic glutamate 2/3 receptors in the ventral tegmental area and the nucleus accumbens shell are involved in behaviors relating to nicotine dependence. Journal of Neuroscience, 27(34), 9077-9085.
112. Liechti, M. E., & Markou, A. (2007). Interactive effects of the mGlu5 receptor antagonist MPEP and the mGlu2/3 receptor antagonist LY341495 on nicotine self-administration and reward deficits associated with nicotine withdrawal in rats. European Journal of Pharmacology, 554(2-3), 164-174. doi:S0014-2999(06)01130-7 [pii]10.1016/j.ejphar.2006.10.011
113. Lind, P. A., Macgregor, S., Vink, J. M., Pergadia, M. L., Hansell, N. K., de Moor, M. H.,... Madden, P. A. F. (2010). A genomewide association study of nicotine and alcohol dependence in Australian and Dutch populations. Twin research and human genetics: the official journal of the International Society for Twin Studies, 13(1), 10-29. doi:10.1375/twin.13.1.10
114. Lips, E. H., Gaborieau, V., McKay, J. D., Chabrier, A., Hung, R. J., Boffetta, P.,... Brennan, P. (2009). Association between a 15q25 gene variant, smoking quantity and tobacco-related cancers among 17 000 individuals. International Journal of Epidemiology. doi:dyp288 [pii]10.1093/ije/dyp288
115. Liu, X., & Jernigan, C. (2011). Activation of the opioid mu1, but not delta or kappa, receptors is required for nicotine reinforcement in a rat model of drug self-administration. Progress in Neuropsychopharmacology &Biological Psychiatry, 35(1), 146-153. doi:10.1016/j.pnpbp.2010.10.007
116. Liu, X., & Stewart, C. (2009). Suppression of nicotine selfadministration by acetylcholinesterase inhibition in rats. 2009 Neuroscience Meeting Planner. Chicago, IL: Society for Neuroscience, Online, 648.5/W17.
117. Lori, A., Tang, Y., O'Malley, S., Picciotto, M. R., Wu, R., Conneely, K. N., & Cubells, J. F. (2011). The Galanin Receptor 1 Gene Associates with Tobacco Craving in Smokers Seeking Cessation Treatment. Neuropsychopharmacology:. doi:10.1038/npp.2011.25
118. Markou, A., & Paterson, N. E. (2001). The nicotinic antagonist methyllycaconitine has differential effects on nicotine self-administration and nicotine withdrawal in the rat. Nicotine& Tobacco Research, 3(4), 361-373. doi:10.1080/14622200110073380
119. Markou, A., & Paterson, N. E. (2009). Multiple motivational forces contribute to nicotine dependence. Nebraska Symposium on Motivation, 55, 65-89.
120. Marx, C. E., Trost, W. T., Shampine, L., Behm, F. M., Giordano, L. A., Massing, M. W., & Rose, J. E. (2006). Neuroactive steroids, negative affect, and nicotine dependence severity in male smokers. Psychopharmacology (Berl), 186(3), 462-472. doi:10.1007/s00213-005-0226-x
121. Maskos, U., Molles, B. E., Pons, S., Besson, M., Guiard, B. P., Guilloux, J. P.,... Changeux, J. P. (2005). Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors. Nature, 436(7047), 103-107. doi:10.1038/nature03694
122. Mata, M. M., Schrier, B. K., & Moore, R. Y. (1977). Interpeduncular nucleus: differential effects of habenula lesions on choline acetyltransferase and glutamic acid decarboxylase. Experimental Neurology, 57(3), 913-921.
123. Mathers, C. D., & Loncar, D. (2006). Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med, 3(11), e442. doi:06-PLME-RA-0071R2 [pii]10.1371/journal. pmed.0030442
124. Matsumoto, M., & Hikosaka, O. (2009). Representation of negative motivational value in the primate lateral habenula. Nature Neuroscience, 12(1), 77-84. doi:10.1038/nn.2233
125. Maze, I., Covington, H. E., 3rd, Dietz, D. M., LaPlant, Q., Renthal, W., Russo, S. J.,... Nestler, E. J. (2010). Essential role of the histone methyltransferase G9a in cocaine-induced plasticity. Science, 327(5962), 213-216. doi:10.1126/science.1179438
126. McGehee, D. S., Heath, M. J., Gelber, S., Devay, P., & Role, L. W. (1995). Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors. Science, 269(5231), 1692-1696.
127. Mihalak, K. B., Carroll, F. I., & Luetje, C. W. (2006). Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors. Molecular Pharmacology, 70(3), 801-805. doi:10.1124/mol.106.025130
128. Mobascher, A., Rujescu, D., Mittelstrass, K., Giegling, I., Lamina, C., Nitz, B.,... Winterer, G. (2010). Association of a variant in the muscarinic acetylcholine receptor 2 gene (CHRM2) with nicotine addiction. American Journal of Medical Genetics. Part B, Neuropsychiatric, 153B(2), 684-690. doi:10.1002/ajmg.b.31011
129. Mugnaini, M., Tessari, M., Tarter, G., Merlo Pich, E., Chiamulera, C., & Bunnemann, B. (2002). Upregulation of [3H] methyllycaconitine binding sites following continuous infusion of nicotine, without changes of alpha7 or alpha6 subunit mRNA: an autoradiography and in situ hybridization study in rat brain. European Journal of Neuroscience, 16(9), 1633-1646.
130. Murray, C. J., & Lopez, A. D. (1997). Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet, 349(9064), 1498-1504.
131. Nakajima, M. (2007). Smoking behavior and related cancers: the role of CYP2A6 polymorphisms. Current Opinion in Molecular Therapeutics, 9(6), 538-544.
132. Naqvi, N. H., Rudrauf, D., Damasio, H., & Bechara, A. (2007). Damage to the insula disrupts addiction to cigarette smoking. Science, 315(5811), 531-534.
133. Nedic, G., Nikolac, M., Borovecki, F., Hajnsek, S., Muck-Seler, D., & Pivac, N. (2010). Association study of a functional catechol-O-methyltransferase polymorphism and smoking in healthy Caucasian subjects. Neuroscience Letters, 473(3), 216-219. doi:10.1016/j.neulet.2010.02.050
134. Nelson, M. E., Kuryatov, A., Choi, C. H., Zhou, Y., & Lindstrom, J. (2003). Alternate stoichiometries of alpha4beta2 nicotinic acetylcholine receptors. Molecular Pharmacology, 63(2), 332-341.
135. Nussbaum, J., Xu, Q., Payne, T. J., Ma, J. Z., Huang, W., Gelernter, J., & Li, M. D. (2008). Significant association of the neurexin-1 gene (NRXN1) with nicotine dependence in European- and African-American smokers. Human Molecular Genetics, 17(11), 1569-1577. doi:10.1093/hmg/ddn044
136. Oliver, M. F. (2012). Retrospective Commentary: the Clofibrate Saga. British Journal of Clinical Pharmacology. doi:10.1111/j.1365-2125.2012.04282.x
137. Oncken, C., Gonzales, D., Nides, M., Rennard, S., Watsky, E., Billing, C. B.,... Reeves, K. (2006). Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation. Archives of Internal Medicine, 166(15), 1571-1577. doi:10.1001/archinte.166.15.1571
138. Palmatier, M. I., Liu, X., Donny, E. C., Caggiula, A. R., & Sved, A. F. (2008). Metabotropic glutamate 5 receptor (mGluR5) antagonists decrease nicotine seeking, but do not affect the reinforcement enhancing effects of nicotine. Neuropsychopharmacology, 33(9), 2139-2147. doi:1301623 [pii]10.1038/sj.npp.1301623
139. Pandhare, A., Hamouda, A. K., Staggs, B., Aggarwal, S., Duddempudi, P. K., Lever, J.,... Blanton, M. P. (2012). Bupropion binds to two sites in the Torpedo nicotinic acetylcholine receptor transmembrane domain: a photoaffinity labeling study with the bupropion analogue [(125)I]-SADU-3-72. Biochemistry, 51(12), 2425-2435. doi:10.1021/bi300101r
140. Panlilio, L. V., Justinova, Z., Mascia, P., Pistis, M., Luchicchi, A., Lecca, S.,... Goldberg, S. R. (2012). Novel use of a lipid-lowering fibrate medication to prevent nicotine reward and relapse: preclinical findings. Neuropsychopharmacology. doi:10.1038/npp.2012.31
141. Pastor, V., Host, L., Zwiller, J., & Bernabeu, R. (2011). Histone deacetylase inhibition decreases preference without affecting aversion for nicotine. Journal of Neurochemistry, 116(4), 636-645. doi:10.1111/j.1471-4159.2010.07149.x
142. Paterson, N. E., & Markou, A. (2005). The metabotropic glutamate receptor 5 antagonist MPEP decreased break points for nicotine, cocaine and food in rats. Psychopharmacology (Berl), 179(1), 255-261. doi:10.1007/s00213-004-2070-9
143. Paterson, N. E., Semenova, S., Gasparini, F., & Markou, A. (2003). The mGluR5 antagonist MPEP decreased nicotine selfadministration in rats and mice. Psychopharmacology (Berl), 167(3), 257-264. doi:10.1007/s00213-003-1432-z
144. Paterson, N. E., Vlachou, S., Guery, S., Kaupmann, K., Froestl, W., & Markou, A. (2008). Positive modulation of GABA(B) receptors decreased nicotine self-administration and counteracted nicotine-induced enhancement of brain reward function in rats. Journal of Pharmacology & Experimental Therapeutics, 326(1), 306-314. doi:jpet.108.139204 [pii]10.1124/jpet.108.139204
145. Peto, R., Darby, S., Deo, H., Silcocks, P., Whitley, E., & Doll, R. (2000). Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies. British Medical Journal, 321(7257), 323-329.
146. Picciotto, M. R., & Corrigall, W. A. (2002). Neuronal systems underlying behaviors related to nicotine addiction: neural circuits and molecular genetics. Journal of Neuroscience, 22(9), 3338-3341.
147. Picciotto, M. R., Zoli, M., Rimondini, R., Lena, C., Marubio, L. M., Pich, E. M.,... Changeux, J. P. (1998). Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotine. Nature, 391(6663), 173-177. doi:10.1038/34413
148. Plaza-Zabala, A., Maldonado, R., & Berrendero, F. (2012). The hypocretin/orexin system: implications for drug reward and relapse. Molecular Neurobiology. doi:10.1007/s12035-012-8255-z
149. Plaza-Zabala, A., Martin-Garcia, E., de Lecea, L., Maldonado, R., & Berrendero, F. (2010). Hypocretins regulate the anxiogeniclike effects of nicotine and induce reinstatement of nicotineseeking behavior. Journal of Neuroscience, 30(6), 2300-2310. doi:30/6/2300 [pii]10.1523/JNEUROSCI.5724-09.2010
150. Polina, E. R., Contini, V., Hutz, M. H., & Bau, C. H. (2009). The serotonin 2A receptor gene in alcohol dependence and tobacco smoking. Drug and Alcohol Dependence, 101(1-2), 128-131. doi:10.1016/j.drugalcdep.2008.11.001
151. Pollock, A. (2011). Antismoking vaccine fails in late trial. New York Times. Retrieved from http://prescriptions.blogs.nytimes.com/2011/07/18/antismoking-vaccine-fails-in-late-trial/
152. Pons, S., Fattore, L., Cossu, G., Tolu, S., Porcu, E., McIntosh, J. M.,... Fratta, W. (2008). Crucial role of alpha4 and alpha6 nicotinic acetylcholine receptor subunits from ventral tegmental area in systemic nicotine self-administration. Journal of Neuroscience, 28(47), 12318-12327. doi:28/47/12318 [pii]10.1523/JNEUROSCI.3918-08.2008
153. Quik, M., Polonskaya, Y., Gillespie, A., Jakowec, M., Lloyd, G. K., & Langston, J. W. (2000). Localization of nicotinic receptor subunit mRNAs in monkey brain by in situ hybridization. Journal of Comparative Neurology, 425(1), 58-69.
154. Reavill, C., Walther, B., Stolerman, I. P., & Testa, B. (1990). Behavioural and pharmacokinetic studies on nicotine, cytisine and lobeline. Neuropharmacology, 29(7), 619-624.
155. Reid, R. D., Quinlan, B., Riley, D. L., & Pipe, A. L. (2007). Smoking cessation: lessons learned from clinical trial evidence. Current Opinion in Cardiology, 22(4), 280-285. doi:10.1097/HCO.0b013e328236740a00001573-200707000-00004 [pii]
156. Ren, J., Qin, C., Hu, F., Tan, J., Qiu, L., Zhao, S.,... Luo, M. (2011). Habenula "cholinergic" neurons co-release glutamate and acetylcholine and activate postsynaptic neurons via distinct transmission modes. Neuron, 69(3), 445-452. doi:10.1016/j. neuron.2010.12.038
157. Renthal, W., Kumar, A., Xiao, G., Wilkinson, M., Covington, H. E., 3rd, Maze, I.,... Nestler, E. J. (2009). Genome-wide analysis of chromatin regulation by cocaine reveals a role for sirtuins. Neuron, 62(3), 335-348. doi:10.1016/j.neuron.2009.03.026
158. Renthal, W., Maze, I., Krishnan, V., Covington, H. E., 3rd, Xiao, G., Kumar, A.,... Kippin, T. (2007). Histone deacetylase 5 epigenetically controls behavioral adaptations to chronic emotional stimuli. Neuron, 56(3), 517-529. doi:10.1016/j. neuron.2007.09.032
159. Renthal, W., & Nestler, E. J. (2008). Epigenetic mechanisms in drug addiction. Trends in Molecular Medicine, 14(8), 341-350. doi:S1471-4914(08)00135-4 [pii]10.1016/j.molmed.2008. 06.004
160. Reperant, C., Pons, S., Dufour, E., Rollema, H., Gardier, A. M., & Maskos, U. (2010). Effect of the alpha4beta2&z.ast; nicotinic acetylcholine receptor partial agonist varenicline on dopamine release in beta2 knock-out mice with selective re-expression of the beta2 subunit in the ventral tegmental area. Neuropharmacology, 58(2), 346-350. doi:10.1016/j.neuropharm. 2009.10.007
161. Reus, V. I., Obach, R. S., Coe, J. W., Faessel, H., Rollema, H., Watsky, E., & Reeves, K. (2007). Varenicline: new treatment with efficacy in smoking cessation. Drugs Today (Barc), 43(2), 65-75. doi:1069956 [pii]10.1358/dot.2007.43.2.1069956
162. Ring, H. Z., Valdes, A. M., Nishita, D. M., Prasad, S., Jacob, P., 3rd, Tyndale, R. F.,... Benowitz, N. L. (2007). Gene-gene interactions between CYP2B6 and CYP2A6 in nicotine metabolism. Pharmacogenetics and Genomics, 17(12), 1007-1015. doi:10.1097/01.fpc.0000220560.59972.33
163. Rollema, H., Shrikhande, A., Ward, K. M., Tingley Iii, F. D., Coe, J. W., O'Neill, B. T.,... Bertrand, D. (2010). Pre-clinical properties of the alpha4beta2 nicotinic acetylcholine receptor partial agonists varenicline, cytisine and dianicline translate to clinical efficacy for nicotine dependence. British Journal of Pharmacology. doi:BPH682 [pii]10.1111/j.1476-5381.2010.00682.x
164. Saccone, N. L., Saccone, S. F., Hinrichs, A. L., Stitzel, J. A., Duan, W., Pergadia, M. L.,... Bierut, L. J. (2009). Multiple distinct risk loci for nicotine dependence identified by dense coverage of the complete family of nicotinic receptor subunit (CHRN) genes. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics, 150B(4), 453-466. doi:10.1002/ajmg.b.30828
165. Saccone, N. L., Wang, J. C., Breslau, N., Johnson, E. O., Hatsukami, D., Saccone, S. F.,... Bierut, L. J. (2009). The CHRNA5-CHRNA3-CHRNB4 nicotinic receptor subunit gene cluster affects risk for nicotine dependence in African-Americans and in European-Americans. Cancer Research, 69(17), 6848-6856. doi:10.1158/0008-5472.CAN-09-0786
166. Saccone, S. F., Hinrichs, A. L., Saccone, N. L., Chase, G. A., Konvicka, K., Madden, P. A.,... Bierut, L. J. (2007). Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs. Human Molecular Genetics, 16, 36-49.
167. Salminen, O., Murphy, K. L., McIntosh, J. M., Drago, J., Marks, M. J., Collins, A. C., & Grady, S. R. (2004). Subunit composition and pharmacology of two classes of striatal presynaptic nicotinic acetylcholine receptors mediating dopamine release in mice. Molecular Pharmacology, 65(6), 1526-1535.
168. Sato, N., Kageyama, S., Chen, R., Suzuki, M., Mori, H., Tanioka, F.,... Sugimura, H. (2010). Association between neuropeptide Y receptor 2 polymorphism and the smoking behavior of elderly Japanese. Journal of Human Genetics, 55(11), 755-760. doi:10.1038/jhg.2010.108
169. Schaefer, A., Im, H. I., Veno, M. T., Fowler, C. D., Min, A., Intrator, A.,... Greengard, P. (2010). Argonaute 2 in dopamine 2 receptor-expressing neurons regulates cocaine addiction. The Journal of Experimental Medicine, 207(9), 1843-1851. doi:10.1084/jem.20100451
170. Scharfenberg, G., Benndorf, S., & Kempe, G. (1971). Cytisine (Tabex) as a pharmaceutical aid in stopping smoking. Dtsch Gesundheitsw, 26(10), 463-465.
171. Scherer, G. (1999). Smoking behaviour and compensation: a review of the literature. Psychopharmacology, 145(1), 1-20.
172. Schlaepfer, I. R., Hoft, N. R., Collins, A. C., Corley, R. P., Hewitt, J. K., Hopfer, C. J.,... Ehringer, M. A. (2008). The CHRNA5/A3/B4 gene cluster variability as an important determinant of early alcohol and tobacco initiation in young adults. Biological Psychiatry, 63(11), 1039-1046. doi:10.1016/j. biopsych.2007.10.024
173. Sellers, E. M., Tyndale, R. F., & Fernandes, L. C. (2003). Decreasing smoking behaviour and risk through CYP2A6 inhibition. Drug Discovery Today, 8(11), 487-493.
174. Sherva, R., Wilhelmsen, K., Pomerleau, C. S., Chasse, S. A., Rice, J. P., Snedecor, S. M.,... Pomerleau, O. F. (2008). Association of a single nucleotide polymorphism in neuronal acetylcholine receptor subunit alpha 5 (CHRNA5) with smoking status and with 'pleasurable buzz' during early experimentation with smoking. Addiction, 103(9), 1544-1552. doi:10.1111/j.1360-0443.2008.02279.x
175. Slemmer, J. E., Martin, B. R., & Damaj, M. I. (2000). Bupropion is a nicotinic antagonist. Journal of Pharmacology & Experimental Therapeutics, 295(1), 321-327.
176. Stevens, V. L., Bierut, L. J., Talbot, J. T., Wang, J. C., Sun, J., Hinrichs, A. L.,... Calle, E. E. (2008). Nicotinic receptor gene variants influence susceptibility to heavy smoking. Cancer Epidemiology, Biomarkers & Prevention, 17(12), 3517-3525. doi:10.1158/1055-9965.EPI-08-0585
177. Stolerman, I. P., & Jarvis, M. J. (1995). The scientific case that nicotine is addictive. Psychopharmacology (Berl), 117(1), 2-10; discussion 14-20.
178. Stolerman, I. P., Mirza, N. R., & Shoaib, M. (1995). Nicotine psychopharmacology: addiction, cognition and neuroadaptation. Medicinal Research Reviews, 15(1), 47-72.
179. Stopponi, S., Somaini, L., Cippitelli, A., Cannella, N., Braconi, S., Kallupi, M.,... Ciccocioppo, R. (2011). Activation of nuclear PPAR gamma receptors by the antidiabetic agent pioglitazone suppresses alcohol drinking and relapse to alcohol seeking. Biological Psychiatry, 69(7), 642-649. doi:10.1016/j. biopsych.2010.12.010
180. Sugama, S., Cho, B. P., Baker, H., Joh, T. H., Lucero, J., & Conti, B. (2002). Neurons of the superior nucleus of the medial habenula and ependymal cells express IL-18 in rat CNS. Brain Research, 958(1), 1-9.
181. Sun, D., Ma, J. Z., Payne, T. J., & Li, M. D. (2008). Beta-arrestins 1 and 2 are associated with nicotine dependence in European American smokers. Molecular Psychiatry, 13(4), 398-406. doi:10.1038/sj.mp.4002036
182. Tanda, G., Kopajtic, T. A., & Katz, J. L. (2008). Cocainelike neurochemical effects of antihistaminic medications. Journal of Neurochemistry, 106(1), 147-157. doi:10.1111/j.1471-4159.2008.05361.x
183. Tapper, A. R., McKinney, S. L., Nashmi, R., Schwarz, J., Deshpande, P., Labarca, C.,... Lester, H. A. (2004). Nicotine activation of alpha4&z.ast; receptors: sufficient for reward, tolerance, and sensitization. Science, 306(5698), 1029-1032. doi:10.1126/science.1099420
184. Thorgeirsson, T. E., Geller, F., Sulem, P., Rafnar, T., Wiste, A., Magnusson, K. P.,... Stefansson, K. (2008). A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature, 452(7187), 638-642. doi:10.1038/nature06846
185. Thorgeirsson, T. E., Gudbjartsson, D. F., Surakka, I., Vink, J. M., Amin, N., Geller, F.,... Dirksen, A. (2010). Sequence variants at CHRNB3-CHRNA6 and CYP2A6 affect smoking behavior. Nature Genetics, 42(5), 448-453. doi:10.1038/ng.573
186. Toll, L., Zaveri, N. T., Polgar, W. E., Jiang, F., Khroyan, T. V., Zhou, W.,... Leslie, F. M. (2012). AT-1001: a high affinity and selective alpha3beta4 nicotinic acetylcholine receptor antagonist blocks nicotine self-administration in rats. Neuropsychopharmacology, 37(6), 1367-1376. doi:10.1038/npp.2011.322
187. Tonstad, S., & Aubin, H. J. (2012). Efficacy of a dose range of surinabant, a cannabinoid receptor blocker, for smoking cessation: a randomized controlled clinical trial. Journal of Psychopharmacology. doi:10.1177/0269881111431623
188. Vincent, S. R., Staines, W. A., McGeer, E. G., & Fibiger, H. C. (1980). Transmitters contained in the efferents of the habenula. Brain Res, 195(2), 479-484.
189. Vink, J. M., Smit, A. B., de Geus, E. J., Sullivan, P., Willemsen, G., Hottenga, J. J., ... Boomsma, D. I. (2009). Genome-wide association study of smoking initiation and current smoking. American Journal of Human Genetics, 84(3), 367-379. doi:10.1016/j. ajhg.2009.02.001
190. Vlachou, S., Paterson, N. E., Guery, S., Kaupmann, K., Froestl, W., Banerjee, D.,... Markou, A. (2011). Both GABA(B) receptor activation and blockade exacerbated anhedonic aspects of nicotine withdrawal in rats. European Journal of Pharmacology, 655(1-3), 52-58. doi:10.1016/j.ejphar.2011.01.009
191. Wang, J. C., Cruchaga, C., Saccone, N. L., Bertelsen, S., Liu, P., Budde, J. P.,... Goate, A. M. (2009). Risk for nicotine dependence and lung cancer is conferred by mRNA expression levels and amino acid change in CHRNA5. Human Molecular Genetics, 18(16), 3125-3135. doi:10.1093/hmg/ddp231
192. Wang, Y., Broderick, P., Matakidou, A., Eisen, T., & Houlston, R. S. (2010). Role of 5p15.33 (TERT-CLPTM1L), 6p21.33 and 15q25.1 (CHRNA5-CHRNA3) variation and lung cancer risk in never-smokers. Carcinogenesis, 31(2), 234-238. doi:bgp287 [pii]10.1093/carcin/bgp287
193. Weiss, R. B., Baker, T. B., Cannon, D. S., von Niederhausern, A., Dunn, D. M., Matsunami, N.,... Leppert, M. F. (2008). A candidate gene approach identifies the CHRNA5-A3-B4 region as a risk factor for age-dependent nicotine addiction. PLoS Genetics, 4(7), e1000125. doi:10.1371/journal.pgen.1000125
194. White, M. J., Young, R. M., Morris, C. P., & Lawford, B. R. (2011). Cigarette smoking in young adults: The influence of the HTR2A T102C polymorphism and punishment sensitivity. Drug and Alcohol Dependence, 114(2-3), 140-146. doi:10.1016/j. drugalcdep.2010.08.014
195. Wonnacott, S., Sidhpura, N., & Balfour, D. J. (2005). Nicotine: from molecular mechanisms to behaviour. Current Opinion in Pharmacolology, 5(1), 53-59. doi:S1471-4892(04)00194-8 [pii]10.1016/j.coph.2004.12.002
196. Yamanaka, A., Tsujino, N., Funahashi, H., Honda, K., Guan, J. L., Wang, Q. P.,... Sakurai, T. (2002). Orexins activate histaminergic neurons via the orexin 2 receptor. Biochemical and Biophysical Research Communications, 290(4), 1237-1245.
197. Zhang, L., Kendler, K. S., & Chen, X. (2006). Association of the phosphatase and tensin homolog gene (PTEN) with smoking initiation and nicotine dependence. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics, 141B(1), 10-14. doi:10.1002/ajmg.b.30240
198. Zhao, Q., Schwam, E., Fullerton, T., O'Gorman, M., & Burstein, A. H. (2011). Pharmacokinetics, safety, and tolerability following multiple oral doses of varenicline under various titration schedules in elderly nonsmokers. Journal of Clinical Pharmacology, 51(4), 492-501. doi:10.1177/0091270010370461
199. Zeiger, J. S., Haberstick, B. C., Schlaepfer, I., Collins, A. C., Corley, R. P., Crowley, T. J.,... Ehringer, M. A. (2008). The neuronal nicotinic receptor subunit genes (CHRNA6 and CHRNB3) are associated with subjective responses to tobacco. Human Molecular Genetics, 17(5), 724-734. doi:10.1093/hmg/ddm344
200. Zoli, M., Moretti, M., Zanardi, A., McIntosh, J. M., Clementi, F., & Gotti, C. (2002). Identification of the nicotinic receptor subtypes expressed on dopaminergic terminals in the rat striatum. Journal of Neuroscience, 22(20), 8785-8789.
201. Zwart, R., & Vijverberg, H. P. (1998). Four pharmacologically distinct subtypes of alpha4beta2 nicotinic acetylcholine receptor expressed in Xenopus laevis oocytes. Molecular Pharmacology, 54(6), 1124-1131.